In this task, you are given text for US Congressional and California state bills, your task is to generate a summary for this bill.

SECTION 1. SHORT TITLE.

This Act may be cited as the ''One Dollar Coin and Community
Development Act of 1994''.

SEC. 2. ONE DOLLAR COINS.

(a) Color and Content.--Section 5112(b) of title 31, United States
Code, is amended--
(1) in the 1st sentence, by striking ''dollar,''; and
(2) by inserting after the 4th sentence, the following new
sentence: ''The dollar coin shall be golden in color, have an
unreeded edge, have tactile and visual features that make the
denomination of the coin readily discernible, be minted and
fabricated in the United States, and have such metallic,
anticounterfeiting properties as United States clad coinage in
circulation on the date of the enactment of the One Dollar Coin
and Community Development Act of 1994.''.
(b) Design of Dollar Coin.--Section 5112(d)(1) of title 31, United
States Code, is amended by striking the 5th and 6th sentences and
inserting the following new sentence: ''The Secretary of the Treasury
shall select an appropriate design for the obverse side of the
dollar.''.
(c) Effective Date.--Not later than 18 months after the date of
enactment of this Act, the Secretary of the Treasury shall place into
circulation 1 dollar coins authorized under subsection (a)(1) of
section 5112 of title 31, United States Code, which comply with the
design requirements of subsections (b) and (d)(1) of such section, as
amended by subsections (a) and (b) of this section. The Secretary may
include such coins in any numismatic set produced by the United States
Mint before the date the coins are placed in circulation.

SEC. 3. CEASING ISSUANCE OF ONE DOLLAR NOTES.

(a) In General.--After the date that coins described in section
2(c) are first placed in circulation, no Federal reserve bank may order
or place into circulation any $1 Federal reserve note.
(b) Redemption of $1 Notes.--
(1) In general.--Section 5119(b)(1) of title 31, United
States Code, is amended by adding at the end the following new
subparagraph:
''(F) Federal reserve notes in the denomination of
$1.''.
(2) Effective date.--
(A) In general.--The amendment made by paragraph
(1) shall take effect on the date on which coins minted
pursuant to the amendments made by section 2 are first
placed in circulation.
(B) Notice of effective date.--The Secretary of the
Treasury shall publish a notice in the Federal Register
of the date on which the amendment made by paragraph
(1) takes effect in accordance with subparagraph (A) of
this paragraph.
(c) Exception.--The Secretary of the Treasury shall produce only
such Federal reserve notes of 1 dollar denomination as are required
from time to time to meet the needs of collectors of this series. Such
notes shall be produced in sheets and sold by the Secretary, in whole,
or in part, at a price that exceeds the face value of the currency by
an amount that, at a minimum, reimburses the Secretary for the cost of
production.

SEC. 4. RESERVE FUND FOR CIRCULATING COINAGE.

(a) Establishment.--Section 5111(b) of title 31, United States
Code, is amended to read as follows:
''(b) Coinage Funds.--
''(1) Coinage metal fund.--The Secretary of the Treasury--
''(A) shall maintain a coinage metal fund in the
Department of the Treasury; and
''(B) may use the fund to buy metal to mint coins.
''(2) Circulating coinage reserve fund.--
''(A) Establishment.--The Secretary of the Treasury
shall maintain a circulating coinage reserve fund in
the Department of the Treasury.
''(B) Credits and debits.--The Secretary shall--
''(i) credit the coinage reserve fund with
the amount by which the nominal value of the
coins minted and placed into circulation under
this subchapter (other than numismatic items)
exceeds the cost of the metal; and
''(ii) charge the account with--
''(I) the waste incurred in minting
the coins referred to in clause (i);
and
''(II) the cost of distributing the
coins, including the cost of coin bags
and pallets.
''(C) Availability of funds for community
development.--
''(i) In general.--Effective for any fiscal
year only to the extent and in such amounts as
are provided in advance in appropriation Acts,
the Secretary may lend excess amounts in the
circulating coinage reserve fund to the
Community Development Institutions Fund for the
provision of financial assistance by such Fund
through deposits, credit union shares, and
loans in accordance with section 108 of the
Community Development Banking and Financial
Institutions Act of 1994.
''(ii) Terms and conditions.--Any loan by
the Secretary to the Community Development
Institutions Fund in accordance with clause (i)
shall bear such rate of interest and be subject
to such other terms and conditions as the
Secretary determines to be appropriate.
''(D) Investment of balance in account.--Subject to
subparagraph (C), the Secretary of the Treasury shall
invest excess amounts in the circulating coinage
reserve fund in--
''(i) instruments issued by the Secretary
under chapter 31; and
''(ii) other instruments to the extent, and
in such amounts, as may be authorized by law.
''(E) Payment to general fund.--Interest,
dividends, and other earnings on investments of the
circulating coinage reserve fund, including interest on
loans to the Community Development Financial
Institutions Fund, shall be paid into the general fund
of the Treasury to assist in reducing the deficit.''.
(b) Termination of Coinage Profit Fund.--The coinage profit fund is
hereby abolished and any balance in the account as of such termination
shall be transferred by the Secretary to the circulating coinage
reserve fund established pursuant to the amendment made by subsection
(a) as soon as practicable after the date of the enactment of this Act.
One Dollar Coin and Community Development Act of 1994 - Amends Federal monetary law to prescribe specifications for and design of dollar coins, including a golden color.
Proscribes any issuance of one dollar notes after the date that dollar coins are first placed in circulation. Prescribes guidelines for the redemption of one dollar notes.
Directs the Secretary of the Treasury to establish: (1) a coinage metal fund; and (2) a circulating coinage reserve fund.
Authorizes the Secretary to lend excess amounts in the circulating coinage reserve fund to the Community Development Institutions Fund to enable it to provide financial assistance. Mandates that earnings on investments of the circulating coinage reserve fund be paid into the general fund of the Treasury.
Abolishes the coinage profit fund. Transfers the balance of its account to the circulating coinage reserve fund.

SECTION 1. SHORT TITLE.

This Act may be cited as the ''Electronic Warfare Capabilities
Enhancement Act of 2016''.

SEC. 2. FIELDING OF ELECTROMAGNETIC SPECTRUM WARFARE SYSTEMS AND
ELECTRONIC WARFARE CAPABILITIES.

Funds authorized to be appropriated for electromagnetic spectrum
warfare systems and electronic warfare may be used for the development
and fielding of electromagnetic spectrum warfare systems and electronic
warfare capabilities.

SEC. 3. INCLUSION OF ELECTRONIC WARFARE PROGRAMS IN THE RAPID
ACQUISITION AUTHORITY PROGRAM.

(a) In General.--Section 806(c)(1) of the Bob Stump National
Defense Authorization Act for Fiscal Year 2003 (Public Law 107-314; 10
U.S.C. 2302 note) is amended by adding at the end the following new
subparagraph:
''(D)(i) In the case of any supplies and associated support
services that, as determined in writing by the Secretary of
Defense without delegation, are urgently needed to eliminate a
deficiency in electronic warfare that if left unfilled is
likely to result in critical mission failure, the loss of life,
property destruction, or economic effects, the Secretary may
use the procedures developed under this section in order to
accomplish the rapid acquisition and deployment of needed
offensive or defensive electronic warfare capabilities,
supplies, and associated support services.
''(ii) The Secretary of Defense shall ensure, to the extent
practicable, that for the purposes of electronic warfare
acquisition, the Department of Defense shall consider use of
the following procedures:
''(I) The rapid acquisition authority provided
under this section.
''(II) Use of other transactions authority provided
under section 2371 of title 10, United States Code.
''(III) The acquisition of commercial items using
simplified acquisition procedures.
''(IV) The authority for procurement for
experimental purposes provided under section 2373 of
title 10, United States Code.
''(iii) In this subparagraph, the term 'electronic warfare'
means military action involving the use of electromagnetic and
directed energy to control the electromagnetic spectrum or to
attack the enemy, and includes electromagnetic spectrum
warfare, which encompasses military communications and sensing
operations that occur in the electromagnetic operational
domain.''.
(b) Conforming Amendments.--Section 2373 of title 10, United States
Code, is amended--
(1) in subsection (a), by striking ''and aeronautical
supplies'' and inserting '', aeronautical supplies, and
electronic warfare''; and
(2) by adding at the end of the following new subsection:
''(c) Electronic Warfare Defined.--The term 'electronic warfare'
means military action involving the use of electromagnetic and directed
energy to control the electromagnetic spectrum or to attack the enemy,
and includes electromagnetic spectrum warfare, which encompasses
military communications and sensing operations that occur in the
electromagnetic operational domain.''.

SEC. 4. AUTHORITY TO WAIVE THE JOINT REQUIREMENTS OVERSIGHT COUNCIL
(JROC) FOR CERTAIN ELECTRONIC WARFARE PROGRAMS.

(a) Alternate Review.--The Secretary of Defense shall delegate to
the Office of the Secretary of Defense's senior electronic warfare
executive the authority to review and validate all Joint Capabilities
Integration and Development System documents for electronic warfare
acquisition programs notwithstanding section 181 of title 10, United
States Code.
(b) JROC Appeal.--The Joint Requirements Oversight Council may
appeal to the Office of the Secretary of Defense to review any program
through the normal Joint Capabilities Integration and Development
System process.

SEC. 5. ELECTRONIC WARFARE EXECUTIVE COMMITTEE REPORTS TO CONGRESS.

(a) In General.--Not later than 270 days after the date of the
enactment of this Act, the Electronic Warfare Executive Committee shall
submit to the congressional defense committees a strategic plan with
measurable and timely objectives to achieve its mission according to
the following metrics:
(1) Progress on intra-service ground and air
interoperabilities.
(2) Progress in streamlining the requirements, acquisition,
and budget process to further a rapid electronic warfare
acquisition process.
(3) The efficiency and effectiveness of the acquisition
process for priority electronic warfare items.
(4) The training methods and requirements of the military
services for training in contested electronic warfare
environments.
(5) Capability gaps with respect to near-peer adversaries
identified pursuant to a capability gap assessment.
(6) A joint strategy on achieving near real-time system
adaption to rapidly advancing modern digital electronics.
(7) Progress on increasing innovative electromagnetic
spectrum warfighting methods and operational concepts that
provide advantages within the electromagnetic spectrum
operational domain.
(b) Congressional Defense Committees Defined.--In this section, the
term ''congressional defense committees'' means--
(1) the Committee on Armed Services and the Committee on
Appropriations of the Senate; and
(2) the Committee on Armed Services and the Committee on
Appropriations of the House of Representatives.
Electronic Warfare Capabilities Enhancement Act of 2016 This bill permits the use of appropriations authorized for electromagnetic spectrum warfare systems and electronic warfare in order to develop and field electromagnetic spectrum warfare systems and electronic warfare capabilities. The Bob Stump National Defense Authorization Act for Fiscal Year 2003 is amended to include electronic warfare programs in the rapid acquisition authority program. Electronic warfare is military action involving the use of electromagnetic and directed energy to control the electromagnetic spectrum or to attack the enemy, and includes electromagnetic spectrum warfare, which encompasses military communications and sensing operations that occur in the electromagnetic operational domain. The Department of Defense shall delegate to the senior electronic warfare executive the authority to review and validate all Joint Capabilities Integration and Development System documents for electronic warfare acquisition programs. The Electronic Warfare Executive Committee shall submit to the congressional defense committees a strategic plan with measurable and timely objectives to achieve its mission according to specified metrics.

SECTION 1. SHORT TITLE.

This Act may be cited as the ''Unlocking Lifesaving Treatments for
Rare-Diseases Act'' or ''ULTRA''.

SEC. 2. IMPROVING THE ACCELERATED APPROVAL PATHWAY FOR FAST TRACK
PRODUCTS TO SERVE THE UNMET NEEDS OF INDIVIDUALS WITH
ULTRA RARE DISEASES.

Section 506 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C.
356) is amended by adding at the end the following:
''(e) Scientific Standards for Approval of Certain Orphan Drugs as
Fast Track Products.--
''(1) In general.--The Secretary may approve an application
for a drug designated under section 526 for a rare disease or
condition as a fast track product using a surrogate endpoint as
described under paragraph (2) if--
''(A) the Secretary makes an initial determination
that the drug is eligible for approval--
''(i) as a drug designated for a rare
disease or condition under section 526; and
''(ii) as a fast track product under this
section; and
''(B) the drug is a treatment for a disease or
condition that affects a small number of patients in
the United States, as determined by the Secretary in
designating the drug for a rare disease or condition
under section 526.
''(2) Surrogate endpoint definition for certain fast track
products.--
''(A) In general.--If a drug meets the criteria
established in paragraph (1), the Secretary--
''(i) may use a surrogate endpoint for the
approval of the drug as a fast track product
based on the existence of reasonable scientific
data that support and qualify the relevance of
the surrogate endpoint to the disease state and
treatment; and
''(ii) shall not require clinical treatment
data or other historical clinical data on the
surrogate endpoint as a prerequisite to
assessment of the surrogate endpoint under this
subsection if such data are not available.
''(B) Use of clinical data.--
''(i) Subject to subparagraph (A)(ii), in a
surrogate endpoint assessment under this
subsection, the Secretary may take into
consideration any reliable clinical data that
are readily available and published.
''(ii) For a surrogate endpoint which the
Secretary decides to use in accordance with
subparagraph (A), nothing in this subsection
shall preclude the Secretary from requiring
clinical data that makes use of the surrogate
endpoint as a condition of approval for the
fast track product.
''(C) Guidance and considerations.--Not later than
1 year after the date of enactment of the Unlocking
Lifesaving Treatments for Rare-Diseases Act, the
Secretary shall issue guidance providing details and
options for qualifying surrogate endpoints without
clinical data pursuant to this subsection. In
qualifying a surrogate endpoint under this subsection,
the Secretary shall take into account and balance the
following considerations:
''(i) The unmet need served by the drug and
the adverse effects of the rare disease or
condition on quality of life and length of
life.
''(ii) The very low likelihood that
clinical data would exist or that clinical
studies would be completed to support a
surrogate endpoint due to the small size of the
patient population in the United States and
other significant barriers inherent in
performing such clinical studies due to the
prevalence of the disease or related factors.
''(iii) The full scope of available basic
scientific data and information describing the
pathophysiology of the disease, mechanism of
action of the drug, biology of the relevant
disease pathway, information regarding the
quality of the biomarker assay, model treatment
data, or other supportive scientific
information that the Secretary deems reasonably
predictive of a clinical benefit in the absence
of clinical data.''.
Unlocking Lifesaving Treatments for Rare-Diseases Act or ULTRA - Amends the Federal Food, Drug, and Cosmetic Act to authorize the Secretary of Health and Human Services (HHS) to approve an application for a drug as a fast track product using a surrogate endpoint, based on the existence of reasonable scientific data that support and qualify the relevance of such endpoint to the disease state and treatment, if the Secretary: (1) makes an initial determination that the drug is eligible for approval as a drug designated for a rare disease or condition (orphan drug) and as a fast track product, and (2) determines that the drug is a treatment for a disease or condition that affects a small number of patients in the United States. Prohibits the Secretary from requiring clinical treatment or other historical clinical data on such endpoint as a prerequisite to assessment of that endpoint if such scientific data is not available.

Directs the Secretary to issue guidance providing details and options for qualifying surrogate endpoints without clinical data, taking into account and balancing: (1) the unmet need served by the drug and the adverse effects of the rare disease or condition on quality and length of life, (2) the very low likelihood that clinical data would exist or that clinical studies would be completed to support a surrogate endpoint due to the small size of the U.S. patient population and other significant barriers inherent in performing such studies due to the prevalence of the disease or related factors, and (3) the full scope of available basic scientific data and information that the Secretary deems reasonably predictive of a clinical benefit in the absence of clinical data.